Abstract:Objective::To investigate the efficacy and safety of the adrenergic α-receptor blocker tolazoline in the treatment of experimental myopia in chicks, and explore its mechanism.Methods::In this experimental study, totally 61 6-day-old White Lehorn chickens were randomly divided into form deprivation control group (FDM), tolazoline treatment group after form deprivation (FDM+T100), tolazoline combined with NOS inhibitor L-NAME group after form deprivation (FDM+T100+L-NAME), lens induction control group (LIM), tolazoline treatment group after lens induction (LIM+T100), and tolazoline combined with NOS inhibitor L-NAME group after lens induction (LIM+T100+L-NAME) for efficacy study. Chickens were also divided into blank control group (Blank) and tolazoline treatment group (Blank+T100) for safety study. The experimental intervention was performed on the right eyes of all chicks. Eyes requiring tolazoline (T100) treatment were injected with 12.5 μL tolazoline, eyes requiring tolazoline combined L-NAME (T100+L-NAME) were injected with equal equivalent tolazoline and L-NAME, and the control group was injected with normal saline for 6 days. The diopter and eye biological parameters of each group before and after treatment were recorded and analyzed statistically. In the safety study, ERG examinations were performed on blank group and blank+T100 group. After sacrificing the chicks, the eyeballs were fixed and sliced for TUNEL staining to observe retinal damage. The experimental group and the control group in different myopia model were compared in pairs in this study. The independent samples t-test was used for diopter, vitreous depth, choroid thickness, and axial length which satisfy the normal distribution, and the Mann-Whitney U test was used for the electroretinogram ratio results which did not meet the normal distribution. Results::After 6 days of treatment, in the form deprivation model, the FDM+T100 group had reduced refractive myopia ( t=-16.16, P<0.001), reduced amount of axial length growth ( t=12.41, P<0.001), and reduced amount of choroidal thickness thinning ( t=-2.46, P=0.031) compared to the FDM group. Compared to the FDM+T100 group, the FDM+T100+L-NAME group had increased refractive myopia ( t=4.20, P=0.001 ), increased amount of axial length growth ( t=-2.33, P=0.033). In the lens induction model, when compared with the LIM group, the refractive diopter was reduced in the LIM+T100 group ( t=-5.77, P<0.001), axial length growth was reduced ( t=4.19, P<0.001). When compared with the LIM+T100 group, the refractive diopter was increased in the LIM+T100+L-NAME group ( t=3.74, P=0.001), and increased amount of axial length growth ( t=-3.20, P=0.005). In the safety study, there was no significant difference in the diopter, the changes of eyeball biological parameters and ERG right/left eye ratio between the blank control group and the simple tolazoline treatment group. No significant apoptosis was found among the groups in TUNEL staining. Conclusions::Tolazoline can effectively delay the diopter and axial progression of experimental myopia in chicks. But this effect was weakened by NOS inhibitor L-NAME. It is suggested that nitric oxide (NO) may also play an important role in the dilation of choroidal blood vessels by tolazoline.

The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens

The Effect of the Nonspecific Nitric Oxide Synthase Inhibitor NG-Nitro-l-Arginine Methyl Ester on the Choroidal Compensatory Response to Myopic Defocus in Chickens

Inhibiting the neuronal isoform of nitric oxide synthase has similar effects on the compensatory choroidal and axial responses to myopic defocus in chicks as does the non-specific inhibitor L-NAME

Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks

Effects of Nitric Oxide Synthase Inhibitor on the Retina of Form-deprivation Myopia

Effects of muscarinic agents on chick choroids in intact eyes and eyecups: evidence for a muscarinic mechanism in choroidal thinning

Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma

Choroidal and scleral mechanisms of compensation for spectacle lenses in chicks

Effectiveness and Safety of Tolazoline in the Experimental Myopia Control in Chicks

Mechanisms of NO-Mediated Protein S-Nitrosylation in the Lens-Induced Myopia

Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia

Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens

Visually induced changes in cytokine production in the chick choroid

Short-Term Effect of Low-Dose Atropine and Hyperopic Defocus on Choroidal Thickness and Axial Length in Young Myopic Adults

Mechanism of myopic defocus or atropine for myopia control: different or similar ways?

Effect of N-G-nitro-L-arginine Methyl Ester on Experimental Uveitis

Studies on the Interactions of Retinal Dopamine with Choroidal Thickness in the Chicken

Vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries in vitro and increased optic disc blood flow in vivo

Analysis of dietary nitrate incorporation in porcine ocular tissues after supplementing 15N-labeled sodium nitrate

Genetic Deletion of the NOS3 Gene in CAV1(-/-) Mice Restores Aqueous Humor Outflow Function

Effects of endogenous dopamine induced by low concentration atropine eye drops on choroidal neovascularization in high myopia mice